Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$80.52 - $93.75 $24,558 - $28,593
-305 Reduced 2.67%
11,124 $940,000
Q1 2022

May 03, 2022

SELL
$80.11 - $90.62 $21,229 - $24,014
-265 Reduced 2.27%
11,429 $1 Million
Q4 2021

Feb 10, 2022

BUY
$79.7 - $88.13 $166,573 - $184,191
2,090 Added 21.76%
11,694 $1.02 Million
Q3 2021

Nov 02, 2021

BUY
$81.78 - $95.14 $63,379 - $73,733
775 Added 8.78%
9,604 $785,000
Q2 2021

Aug 09, 2021

BUY
$85.24 - $94.15 $2,983 - $3,295
35 Added 0.4%
8,829 $806,000
Q1 2021

May 11, 2021

BUY
$83.5 - $98.47 $4,425 - $5,218
53 Added 0.61%
8,794 $752,000
Q4 2020

Feb 03, 2021

SELL
$78.07 - $94.43 $28,495 - $34,466
-365 Reduced 4.01%
8,741 $825,000
Q3 2020

Nov 05, 2020

SELL
$82.14 - $91.0 $59,140 - $65,520
-720 Reduced 7.33%
9,106 $792,000
Q2 2020

Aug 10, 2020

SELL
$80.93 - $91.1 $12,058 - $13,573
-149 Reduced 1.49%
9,826 $858,000
Q1 2020

May 05, 2020

SELL
$70.67 - $99.01 $29,822 - $41,782
-422 Reduced 4.06%
9,975 $822,000
Q3 2019

Nov 07, 2019

SELL
$85.54 - $94.26 $34,216 - $37,704
-400 Reduced 3.7%
10,397 $904,000
Q2 2019

Jul 31, 2019

SELL
$75.4 - $92.8 $104,504 - $128,620
-1,386 Reduced 11.38%
10,797 $986,000
Q1 2019

Apr 23, 2019

SELL
$75.32 - $86.15 $4,820 - $5,513
-64 Reduced 0.52%
12,183 $1.17 Million
Q4 2018

Feb 07, 2019

BUY
$73.66 - $82.02 $15,542 - $17,306
211 Added 1.75%
12,247 $1.05 Million
Q3 2018

Oct 12, 2018

BUY
$66.94 - $77.43 $34,607 - $40,031
517 Added 4.49%
12,036 $1.04 Million
Q2 2018

Jul 30, 2018

SELL
$64.91 - $73.36 $7,983 - $9,023
-123 Reduced 1.06%
11,519 $870,000
Q1 2018

May 11, 2018

SELL
$70.39 - $84.15 $3,871 - $4,628
-55 Reduced 0.47%
11,642 $941,000
Q4 2017

Jan 30, 2018

BUY
$72.33 - $77.64 $39,781 - $42,702
550 Added 4.93%
11,697 $982,000
Q3 2017

Oct 23, 2017

SELL
$74.14 - $77.27 $29,656 - $30,908
-400 Reduced 3.46%
11,147 $957,000
Q2 2017

Aug 07, 2017

BUY
N/A
11,547
11,547 $964,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cutter & CO Brokerage, Inc. Portfolio

Follow Cutter & CO Brokerage, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.